Industry Focus
Healthcare: Bristol-Myers' Revolutionary Cancer Drug Suffers A Big Blow
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:17:51
- Mas informaciones
Informações:
Sinopsis
Bristol-Myers Squibb's Opdivo came up short in a key lung cancer trial, causing shares to plummet. Should investors panic?
